MyFinsight
Home
About
Contact
Back
Income Statement
Ernexa Therapeutics Inc. (ERNA)
source: myfinsight.com
Download
Download image
Net loss
attributable to common...
-$3,147K
(43.16%↑ Y/Y)
Net loss
-$3,139K
(43.23%↑ Y/Y)
Series a preferred
stock dividend
$8K
(0.00%↑ Y/Y)
Loss before income
taxes
-$3,136K
(43.25%↑ Y/Y)
Provision for income taxes
$3K
(0.00%↑ Y/Y)
Total other expense,
net
-$635K
(-6.72%↓ Y/Y)
Loss from operations
-$2,501K
(49.28%↑ Y/Y)
Forward sales contract
expense
-$512K
Other expense, net
-$123K
Total operating
expenses
$2,501K
(-48.78%↓ Y/Y)
General and
administrative
$1,365K
(-64.96%↓ Y/Y)
Research and development
$1,136K
(15.10%↑ Y/Y)
Back